Effect of Combination of Superdisintegrants on the Dissolution Rate: Meclizine Hydrochloride Fast Dissolving Tablets
Keywords:
Dissolution efficiency, Fast onset of action, In vitro dissolution studies, Initial dissolution rate, SuperdisintegrantsAbstract
The aim of the present research is to develop the fast dissolving tablets and to study the effect of combination of superdisintegrants on the dissolution rate by using meclizine hydrochloride as a model drug. Development of oral fast dissolving tablets is mainly to achieve the following objectives; they are to give fast onset of action and to overcome difficulty in swallowing tablets and capsules that resulting in non-compliance. The prepared tablets were characterized for hardness, weight variation, friability, wetting time, water absorption ratio, and disintegration time. In vitro drug release studies were performed by using USP XXIV Type II dissolution apparatus in 0.1 N HCl. From in vitro dissolution studies, the formulation F3 (3% crosscarmellose and 3% crosspovidone) showed rapid dissolution of about 99.34% in 15 min, and disintegration time 39 sec when compared with others. The percent drug release in 15 min (Q15) and initial dissolution rate for formulation F3 was 99.34±0.56%, 6.54%/min. These were very much higher compared to control tablets (36.48±0.82%, 2.43%/min). The dissolution efficiency was found to be increased by 3.5 fold with F3 formulation compared to control tablet. From the stability studies, the similarity index was found to be above 50 that indicates the stability of tablets. In conclusion, development of meclizine hydrochloride fast dissolving tablets using combination of superdisintegrants is showed improved results rather than the tablets with individual superdisintegrants. Further the efficacy of the developed formulations has to be assessed by pharmacokinetic studies.
Downloads
Metrics
References
Bi, Y., Sunanda, H., Yonezawa, Y., Danjo, K., Otuska, A., Iida, K. (1996). Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chemical and Pharmaceutical Bulletin 44(11): 2121-2127.
Chaitanya, P., Jyothi, P., Devadasu, V.R., Venisetty, R.K., Vemula, S.K. (2014). Ezetimibe solid dispersions: formulation, development and in vitro evaluation. American Journal of Advanced Drug Delivery 2(1): 90- 103.
Chaudhary, A., Tiwari, N., Jain, V. (2011). Microporous bilayer osmotic tablet for colon-specific delivery. Europian Journal of Pharmaceutics and Biopharmaceutics 78: 134- 140.
Daravath, B., Tadikonda, R.R., Vemula, S.K. (2014). Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen. Drug Development and Industrial Pharmacy. doi: 10.3109/03639045.2014. 940963.
Elnaggar, Y.S., El-Massik, M.A., Abdallah, O.Y., Ebian, A.E. (2010). Maltodextrin: a novel excipient used in sugar- based orally disintegrating tablets and phase transition process. AAPS PharmSciTech 11(2): 645-651.
George, S., Vasudevan, D. (2012). Studies on the preparation, characterization, and solubility of 2-HP-β- cyclodextrin-meclizine HCl inclusion complexes. Journal of Young Pharmacist 4(4): 220-227.
Gohel, M., Patel, M., Amin, A., Agrawal, R., Dave, R., Bariya,
N. (2004). Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech 5: Article 36.
Goyani, M., Shah, P., Vyas, B., Shah, D. (2012). Formulation and evaluation of orodispersible tablets of meclizine hydrochloride. International Research Journal of Pharmacy 3: 196-199.
Hirani, J.J., Rathod, D.A., Vadalia, K.R. (2009). Orally disintegrating tablets: a review. Tropical Journal of Pharmaceutical Research 8(2): 161-172.
Mahrous, G.M., Shazly, G.A., Ibrahim, M.A. (2011). Formulation and evaluation of meclizine HCl orally disintegrating tablets. Bulletin of Pharmaceutical Sciences 34 (2): 141-148.
Neduri, K., Bontha, V.K., Vemula, S.K. (2013). Different techniques to enhance the dissolution rate of lovastatin: formulation and evaluation. Asian Journal of Pharmaceutical and Clinical Research 1: 56-60.
Nimisha, Pal, P., Srivastava, D. (2012). Formulation and evaluation of meclizine hydro chloride mouth dissolving tablets: An attempt to enhance patient compliance. Indian Journal of Pharmaceutical Science 4(6): 307-311.
Seager, H. (1998). Drug-deliver products and the zydis fast- dissolving dosage form. Journal of Pharmacy and Pharmacology 50: 375-382.
Vangala, M., Veerareddy, P.R., Devadasu, V.R., Vemula,
S.K. (2014). Meclizine hydro chloride fast dissolving tablets by sublimation method: formulation and evaluation. American Journal of Advanced Drug Delivery 2(2): 133-144.
Vaskula S., Vemula, S.K., Bontha, V.K., Garrepally, P. (2012). Liquisolid compacts: An approach to enhance the dissolution rate of nimesulide. Journal of Applied Pharmaceutical Science 02(05): 115-121.
Veerareddy, P.R., Vemula, S.K. (2012). Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurboprofen. Journal of Drug Targeting 20(8): 703-714.
Vemula, S.K., Paulos, B., Kebamo, S. (2014). Formulation and evaluation of meclizine hydrochloride fast dissolving tablets. Proceedings of the National Symposium on “Science, Technology and Innovation for National Development” Wollega University, Nekemte, Ethiopia. ISBN: 978-99944-889-2-6: 140-148.
Vemula, S.K., Bontha, V.K., Garrepally, P., Chilukala, S., Madavapeddi, A.K. (2011). Development and characterization of fast disintegrating tablets of terbinafine hydrochloride. Journal of Pharmacy Research 4(7): 2273- 2275.
Vemula, S.K., Garrepally, P., Bontha, V.K. (2010). Development and characterization of fast disintegrating tablets of Piroxicam. Inventi Impact: Pharm Tech 1(3): 169-173.
Vemula, S.K., Katkum, R. (2014). Development and physical characterization of meclizine hydrochloride solid dispersions by using polyethylene glycol 8000. Science, Technology and Arts Research Journal 3(1): 48-52.
Vemula, S.K., Vangala, M. (2014). Formulation development and characterization of meclizine hydrochloride sublimated fast dissolving tablets. International Scholarly Research Notices 2014: Article ID 281376, 8 pages. doi:10.1155/2014/281376.
Vemula, S.K., Veerareddy, P.R. (2011). Fast disintegrating tablets of flurbiprofen: formulation and characterization. Latin American Journal of Pharmacy 3: 1135-1141.
Vemula, S.K., Veerareddy, P.R. (2013). Formulation, evaluation and pharmacokinetics of ketorolac tromethamine time-dependent colon targeted drug delivery system. Expert Opinion Drug Delivery 10: 33-45.
Vemula, S.K., Bontha, V.K. (2013). Colon targeted gaur gm compression coated tablets of flurbiprofen: formulation, development and pharmacokinetics. BioMed Research International 2013: Article ID 287919, 8 pages. doi:10.1155/2013/287919.
Vemula, S.K., Veerareddy, P.R., Devadasu, V.R. (2014a). Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery. Drug Delivery and Translational Research 4: 310-319.
Vemula, S.K., Veerareddy, P.R., Devadasu, V.R. (2014b). Pharmacokinetics of colon-specific pH and time- dependent flurbiprofen tablets. European Journal of Drug Metabolism and Pharmacokinetics. doi: 10.1007/s13318- 014-0210-0 (Article in Press).
Wang, Z., Lee, B., Pearce, D., Qian, S., Wang, Y., Zhang, Q., Chow, M.S. (2012). Meclizine metabolism and pharmacokinetics: formulation on its absorption. Journal of Clinical Pharmacolology 52(9): 1343-1349.
Downloads
Published
How to Cite
License
Copyright (c) 2015 journal of Science, Technology and Arts Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
STAR © 2023 Copyright; All rights reserved